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Antisense oligodeoxynucleotides targeting ATM
strengthen apoptosis of laryngeal squamous cell
carcinoma grown in nude mice
Jun Feng1,4†, Jian Zou1†, Li Li2, Yongsheng Zhao3 and Shixi Liu1*
Abstract
Background: To conserve laryngeal function and elevate living quality of laryngeal squamous cell carcinoma
(LSCC) patients, we designed antisense oligodeoxynucleotides (AS-ODNs) to reduce expression of ATM and to
enhance the apoptosis of hep-2 (Human epidermoid laryngeal carcinoma) cells to radiation in vitro and in vivo.
Methods: The expression of ATM mRNA and protein in hep-2 cells were examined by real-time quantitative PCR
and western blotting respectively. Clonogenic survival assay was carried out to detect the survival ability of hep-2
cells after irradiation, and analyzed the cell apoptosis by flow cytometry. The volume of solid tumors was
measured, while TUNEL assay and western blotting used to analyze cell apoptosis and protein expression after
irradiation.
Results: The relative ATM mRNA and protein expression in hep-2 cells treated with ATM AS-ODNs were decreased
to 11.03 ± 2.51% and 48.14 ± 5.53% of that in untreated cells respectively (P <0.05). After irradiation, the survival
fraction (SF) of cells treated with ATM AS-ODNs was lower than that of other groups at the same dose of radiation
(P < 0.05). The inhibition rate in hep-2 cells solid tumor exposed to X-ray alone was 5.95 ± 4.52%, while it was
34.28 ± 2.43% in the group which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The
apoptotic index for the group irradiated in combination with ATM AS-ODNs injection was 17.12 ± 4.2%, which was
significantly higher than that of others (P < 0.05).
Conclusion: AS-ODNs of ATM reduce ATM expression and enhance hep-2 cells apoptosis to radiation in vitro and
in vivo.
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Introduction
With advanced technique development in treatments of
LSCC, radiotherapy is superior in its ability to conserve
function in the treatment of initial laryngeal squamous
cell carcinoma (LSCC). However, because of laryngeal
cancer radiation resistance, which result in the low
effectiveness and high recurrence when treated with
radiotherapy alone [1,2]. So it is important significance
to improve the LSCC radiosensitivity. Hep-2 cells, or
laryngeal squamous cell carcinoma cell lines, are helpful
in studying the biological behavior of LSCC. In the latest
study, Hep-2 cells were found to be resistant to radio-
therapy [3]. Ataxia-telangiectasia (A-T) is characterized
by impaired recognition and repair of DNA damage and
increased sensitivity to ionizing radiation (IR) in cancer,
and neurodegeneration [4]. The cytotoxicity of ionizing
radiation is mainly mediated through the generation of
DNA-double strand break (DSB) as evidenced by the
pronounced radiosensitivity of cells and organisms
defective in the machinery of DSB repair[5-7]. Thus,
restraint of DSB repair reveals a mechanism to enhance
the cytotoxicity of IR in tumour cells. ATM (ataxia tel-
angiectasia mutated) is a key protein responsible for
arresting the cell cycle in response to DNA damage and
has a role in genetic stability and cancer susceptibility
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[8-10]. ATM protects the integrity of the genome at dif-
ferent levels: (1) it mediates arrest of the cell cycle at
G1/S, S, and G2/M to prevent the processing of
damaged DNA; (2) it activates DNA-repair pathways;
and (3) it induces apoptosis if the DNA damage is so
detrimental that normal cell function can no longer be
rescued [11-15]. Zou and colleagues have shown that
antisense inhibition of ATM gene enhances the radio-
sensitivity of head and neck squamous cell carcinoma in
mice [16,17]. Sak A reported that the kinase activity of
DNA-PKcs could be specifically inhibited by As-ODNs
and resulted in marked inhibition of DNA-Dsb rejoining
and radiosensitization of human non-small cell lung
cancer (NSCLC) cell line [18]. Leonard CE’s study
showed that the Paclitaxel could enhance the radiosensi-
tivity of squamous carcinoma cell line of the head and
neck in vitro [19]. However, there were no reports
about the antisense oligodeoxynucleotides of ATM
strengthening radio-induced apoptosis of laryngeal squa-
mous cell carcinoma grown in nude mice. Therefore, we
designed to study whether reduction of ATM expression
after antisense oligodeoxynucleotides (AS-ODNs) treat-
ment would result in enhanced radio-induced apoptosis
of Hep-2 cells from BALB/c-nu/nu mice.
Methods
Reagents
Lipofectamine 2000, Opti-MEM I medium and Trizol
kit were bought from Invitrogen Company (Carlsbad,
CA, USA), and anti-GAPDH Monoclonal Antibody
from SAB (Beijing, China). SYBR ExScript RT-PCR Kit,
SYBR Green Master Mix, AnnexinV-FITC-PI, RPMI-
1640 media and 10% heat-inactivated fetal bovine serum
(FBS) were purchased from Takara Biotechnology Com-
pany (Dalian, China). ATM monoclonal antibody was
bought from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). BCIP/NBT alkaline phosphatase substrate kit
IV was purchased from Vector laboratories (Burlingame,
CA, USA). TUNEL apoptosis detection kit was bought
from Roche Company (Shanghai, China).
Cell lines and mice
Hep-2 cell line was obtained from the laboratory of
Head and Neck at Sichuan University. The cells were
maintained in RPMI-1640 medium, supplemented with
10% heat-inactivated fetal bovine serum, 100 μg/mL
streptomycin, and 100 U/mL penicillin G in a humidi-
fied atmosphere of 5% CO2 and 95% air at 37°C. Female
BALB/c-nu/nu mice, aged 3-4 weeks, weighing 18-22 g,
were obtained from the animal centre of West China
Medical School and were maintained in the animal facil-
ity at West China Medical School, Sichuan University in
accordance with nation’s related regulations and animal
welfare requirements.
Synthesis of oligodeoxynucleotides (ODNs) and selection
of target sequences
AS-ODNS, sense (Sen) and mismatch (Mis) ODNs were
synthesized by Shanghai Sangon Biological Engineering
Technology & Services (Shanghai, China). The
sequences were as follows: AS (5’-GTACTAGACT-
CATGGTTCACAATTT-3’); Sen (5’-AAATTGTGAAC-
CATGAGTCTAGTAC-3’) and Mis (5’-AAAATGTAA
ACCATAAGTCTAGAAC-3’). All the ODNs were che-
mically modified to phosphorothioate ODNs by substi-
tuting the oxygen molecules of the phosphate backbone
with sulfur.
Transfection of ODNs in Hep-2 cells
Hep-2 cells at a density of 2 × 105 cells/ml were plated
in 6-cell plates for overnight incubation. Cells were
maintained in RPMI-1640 medium supplemented with
10% FBS at 37°C and 5% CO2. After grew to 70-80%
confluent, cells were replenished with incomplete
RPMI-1640 medium, then treated with ATM AS-ODNs,
ATM Sen-ODNs and Mis-ODNs. The procedures were
as follows: 0.8 ug of ATM AS-ODNs, Sen-ODNs, Mis-
ODNs and 2 mg/ml Lipofectamine 2000 were added to
Opti-MEM I medium separately, and incubated for 5
min at room temperature. Then liposome and ODNs
were mixed and incubated at room temperature for 20
min. Hep-2 cells were washed again with Opti-MEM I
medium before transfection. The liposome ODNs com-
plexes were carefully plated on the cells, and incubated
at 37°C, 5% CO2. After 6 hours transfected cells were
washed twice with PBS. With the medium replaced with
fresh RPMI-1640 medium supplemented with 10% FBS,
the cells were incubated at 37°C overnight. A second
ODNs incubation was performed before cells were
exposed to radiation.
Real-time quantitative PCR analysis
According to the manufacturer’s recommendations total
RNAs were extracted from cultured Hep-2 cells using
Trizol reagent. One-step RT-PCR was performed in
LightCycler-RNA Amplification Kit SYBR Green I.
ATM was amplified with the sense primer: (5’-
GACCGTGGAGAAGTAGAATCAATGG-3’ and the
anti-sense primer: 5’-GGCTCTCTCCAGGTTCGTT
TGC-3’). GAPDH (sense primer: 5’-GAAGGT-
GAAGGTCGGAGT-3’, anti-sense primer: 5’-GAA-
GATGGTGATGGGATTTC-3’) was used as a
housekeeping gene, in order to normalize the expression
of target genes. The reaction mix consisted of 6 mmol/L
MgCl2, 0.4 μl LightCycler-RT-PCR Enzyme Mix and 4
μl LightCycler-RT-PCR Reaction Mix SYBR Green I. All
oligonucleotide primers were designed and synthesized
by Sangon (Shanghai, China). All primers used were at
0.5 μmol/L final concentration. The thermal cycling
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conditions were as follows: 10 min at 55°C for reverse
transcription, 30 seconds at 95°C for pre-denaturation,
42 cycles for 1 second at 95°C for denaturation, 10 sec-
onds at 62°C for annealing and finally, 13 seconds at 72°
C for elongation. At the end of each cycle, the fluores-
cence emitted by the SYBR Green I was measured. After
completion of the cycling process, samples were imme-
diately subjected to a temperature ramp for melting
curve analysis. The relative abundance of target mRNA
in each sample was calculated using the formula sug-
gested by Muller et al[20] which is given by 2-(IL-8 Thresh-
old Cycle)/2-(b-actin Threshold Cycle) × 106 .
Western blot analysis
Total proteins extracted from Hep-2 cells were sepa-
rated on 10% or 15% DS-polyacrylamide gels. The pro-
cedure was briefly described as following: 40
micrograms of cell extract was separated electrophoreti-
cally using sodium dodecyl sulfate-polyacrylamide gel
electrophoresis gel and transferred to nitrocellulose
membranes. The membrane was blocked with 3% milk
powder in nonfat milk in phosphate-buffered saline
(PBS) at room temperature for 6-8 hours, washed with
PBST (PBS containing 0.1% Tween-20) for 10 min three
times. The blot was incubated overnight at 4°C with
rabbit anti-ATM monoclonal antibody per mL in PBS
containing 2.5% nonfat milk, 2.5% bovine serum albu-
min (BSA), and 0.1% Tween 20. The membrane was
washed with PBS containing 0.1% Tween 20 for 15 min
(×4). The membrane was incubated with alkaline phos-
phatase-labeled anti-mouse IgG antibody in TBS con-
taining 1% milk powder at room temperature for 1 hour
and washed again with TBS for 15 min (×1), then 5 min
(×4). Using the BCIP/NBT alkaline phosphatases sub-
strate kit IV, the membrane was briefly visualized. Reac-
tive bands were scanned by Gel Doc 1000 (Bio-Rad).
The experiment was repeated three times.
Irradiation
GWGP-60 Precise radiation system (Beijing, China) was
used to irradiate cells and solid tumor. X-ray irradiation
was carried out at room temperature at a dose rate of
200 cGy/min and equipped with an external 0.5-mm
copper filter.
Clonogenic survival assay
Preliminary studies were conducted to optimize the
number of cells plated in clonogenic assays, aiming at
100 colonies per well. The Hep-2 cells were seeded in
triplicate at limiting dilutions in 6-well plates for about
24 hours in RPMI-1640 medium supplemented with
10% FBS. Then the cells were transfected with ATM
AS-ODNs, ATM Sen-ODNs and Mis-ODNs respec-
tively. About 18 hours after transfection, they were
irradiated simultaneously with different doses of X-ray
radiation (0, 2, 4, 6, and 8 Gy) respectively. The medium
was replaced with a fresh one 24 hours after irradiation.
Colonies were fixed and stained with 0.5% crystal violet,
and the number of colonies containing at least 50 cells,
as examined by microscopy, was recorded 3 to 7 days
later. In each irradiation dose group, surviving fraction
(SF) of cells was calculated as plating efficiency of the
irradiated cells divided by the plating efficiency of
untreated samples.
Apoptosis analyzed by flow cytometry
After 48 hours exposed to 4 Gy radiation, Hep-2 cells
were harvested, and centrifuged at 1500 rpm for 2 min.
Then cells were washed with PBS twice, and fixed in
ice-cold 70% ethanol at 4°C overnight. After rinsing 1 ×
105-1 × 106 cells with 1× Binding Buffer, the cells were
reharvested and resuspended in 200 μl of 1× Binding
Buffer. 5 μl of Annexin V and 10 μl of Propidium Iodide
(PI) were added in cells incubating at room temperature
for 15 min in the dark. Cell apoptotic rate were analyzed
by flow cytometry (Elite ESP, BeckmanCoulter, USA).
Animal experiment
Female BALB/c-nu/nu mice were used to investigate the
effect of ATM AS-ODNs on radio-induced apoptosis of
Hep-2 cells solid tumor. All surgical procedures and
care administered to the animals were in accordance
with institutional guidelines. Animal surgeries and radio-
therapy were performed under general anesthesia, 50
mg/kg ip injection of pentobarbital sodium. About 1 ×
105 Hep-2 cells were subcutaneously inoculated in sub-
mental space of the mice. Tumor growth rates were
determined by measuring two orthogonal dimensional
diameters of each tumor thrice a week. Tumor volumes
were calculated according to the formula V = π/6 × a2
× b, where a is the short axis, and b the long axis.
When tumors reached an average volume of about 200
mm3, the tumor-bearing BALB/c-nu/nu mice were
divided into four groups assigned 8 nude mice in each
group: (a) control group, no treatment; (b) ATM AS-
ODNs group, tumors were treated with ATM AS-ODNs
alone but not exposed to irradiation for each time; (c)
irradiation group, tumors were exposed to X-ray of
2 Gy alone for each time; and (d) combination group,
2.5 mg/kg of ATM AS-ODNs was injected into the solid
tumor the day before X-ray exposure, another dosage of
ATM AS-ODNs was injected right before exposure to
2 Gy of X-ray for each time. The same treatment for
each group was repeated 3 times (the interval time was
5 days). BALB/c-nu/nu mice were killed 3 weeks later.
The ATM protein expression of the tumor in the differ-
ent groups was analyzed by western blot using the pro-
cedures described as above. The tumor inhibition rate
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was calculated using the following formula: (1-average
tumor volume of experimental group/average tumor
volume of control group) ×100%.
TUNEL assay
TUNEL (Terminal deoxynucleotidyltransferase-mediated
dUTPdigoxigenin nick-end-labeling) staining of tumor
sections was performed using an in situ apoptosis detec-
tion kit (Roche, Shanghai, China) according to the man-
ufacture’s protocol. The total number of apoptotic cells
in 10 randomly selected fields was counted. The apopto-
tic index (AI) was calculated as the percentage of posi-
tive staining cells, namely AI = number of apoptotic
cells × 100/total number of nucleated cells.
Statistics
Results were expressed as mean ± standard deviation
(SD) and were analyzed with a one-way ANOVA and
SPSS18.0 software package used to perform statistical
analysis. A value of P < 0.05 was considered significant
between the experimental groups compared with other
groups.
Figure 1 Real-time quantitative PCR analysis of ATM mRNA
expression. Liposome formulations of ATM AS-ODNs decreased
expression of ATM mRNA was notably lower than that of other
groups. There are no significant differences among liposome-treated
group (Lipo), Sen-ODNs (Sen-Lipo) treated group and Mis-ODNs
(Mis-Lipo) treated group (P > 0.05). P < 0.05, AS-ODNs (AS-Lipo)
treated group compared with other groups.
Figure 2 A Effect of ATM AS-ODNs on the expression of ATM
protein in vitro. (A) Liposome formulations of ATM AS-ODNs
dramatically reduced the expression of ATM protein compared with
other groups. (B) There are no significant differences among
liposome-treated group (Lipo), Sen-ODNs (Sen-Lipo) treated group
and Mis-ODNs (Mis-Lipo) treated group (P > 0.05), while the group
treated with ATM AS-ODNs notably different compared with other
groups (**P <0.05).
Figure 3 Survival curves for Hep-2 cells after irradiation .
Survival fractions at each dose point were normalized to untreated
cells. * P < 0.05, the mean of SF4 in the cells transfected with ATM
AS-ODNs was significantly lower than that of other cells.
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Results
Expression of ATM in ATM AS-ODNs transfected Hep-2
cells
To analyze the expression of ATM in mRNA and pro-
tein level in Hep-2 cells, real-time fluorescent quanti-
tative PCR and western blot assay were used
respectively. It is evident that there were no significant
differences among the groups treated with liposome
alone, with Sen-ODNs and with Mis-ODNs after 72
hours treatment (P > 0.05; Figure 1). However when
incubated with liposome formulations of ATM AS-
ODNs, the relative ATM mRNA expression was only
about 11.03 ± 2.51% to the untreated Hep-2 cells,
which showed a significantly reduced expression of
ATM mRNA (P < 0.05;Figure 1). As shown in Figure
2, ATM protein expression was also significantly
reduced by ATM AS-ODNs compared with Sen-
ODNs and Mis-ODNs after 72 hours treatment
(Figure 2A). The relative ATM protein expression of
Hep-2 cells treated with ATM AS-ODNs was only
about 48.14 ± 5.53% to the untreated cells (P < 0.05;
Figure 2B). But there was no significant difference
among the group treated with liposome alone, the
group treated with Sen-ODNs, the group treated with
Mis-ODNs and the group of control untreated Hep-2
cells (P > 0.05; Figure 2B).
ATM AS-ODNs on clonogenic survival ability of Hep-2
cells after irradiation
Cloning efficiency, P <0.05, was declined in cells trans-
fected with ATM AS-ODNs compared with untreated
cells or cells treated with control at the identical radio-
active dose (Figure 3). After 4 Gy radiation, the survival
fraction (SF4) revealed the cellular radio-induced apop-
tosis. The SF4 of cells transfected with ATM AS-ODNs
was 31.3 ± 5.1%, notably lower than that of other cells,
Figure 4 The apoptotic rate of Hep-2 cells after 4 Gy irradiation. P < 0.05, the apoptotic rate (Apo) in ATM AS-ODNs transfected cells
compared with that in Sen-ODNs, Mis-ODNs and Lipofectamine transfected cells after 4 Gy irradiation. * P > 0.05, no significant differences
among Sen-ODNs, Mis-ODNs, Lipo and control groups.
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which indicated a definite increase in the radio-induced
apoptosis (P < 0.05; Figure 3). In clonogenic survival
ability, there were no significant differences compared
with other groups (P > 0.05; Figure 3).
Apoptosis of Hep-2 cells after irradiation in vitro
After 4 Gy irradiation, the apoptotic rate in ATM AS-
ODNs transfected cells was 30.7 ± 1.31%, which was
higher than that in Sen-ODNs and Mis-ODNs trans-
fected cells (P < 0.05; Figure 4).
Inhibitory effect of ATM AS-ODNs on tumor growth in
vivo after irradiation
The homologous ATM protein expression were only
76.84 ± 3.12% and 48.19 ± 3.98% to the untreated group
respectively in the group treated with ATM AS-ODNs
alone and the group irradiated in combination with the
treatment of ATM AS-ODNs (P < 0.05; Figure 5).
Tumor growth of the mice in four groups was shown in
Figure 5. The inhibition rate in Hep-2 cells solid tumor
treated in X-ray alone was 5.95 ± 4.52%, while it was
34.28 ± 2.43% in solid tumor irradiated in combination
with the treatment of ATM AS-ODNs at the experi-
mental endpoint(P < 0.05; Figure 5).
Enhancement of tumor apoptosis by irradiation combined
with ATM AS-ODNs treatment in vivo
There were small numbers of apoptotic cells detected by
TUNEL analysis in tumors treated with irradiation alone,
while the group treated with irradiation in combination
with ATM AS-ODNs was notably higher than that of
irradiation alone (Figure 7A). Accordingly, the AI for
mice tumors treated with irradiation in combination with
ATM AS-ODNs was 17.12 ± 4.2%, significantly higher
than that of the other groups (P <0.05; Figure 7B).
Discussion
Phosphorylation of several DNA damage response pro-
teins, including ATM, p53, can be observed in precursor
stage cancers of the breast, colon, lung, skin, testes, and
urinary bladder [21-23]. It may suggest that DNA damage
occurs during the earliest stages of tumor development,
before genomic instability and the loss of wild-type p53
function in many cancers. Raju V have demonstrated that
p53 induction in response to Myc overexpression requires
the ataxia-telangiectasia mutated (ATM) kinase, a major
regulator of the cellular response to DNA double-strand
breaks[24]. Mohammad A speculated that ATM deficiency
might increase the sensitivity of leukemic blasts to the
chemotherapy used during induction and after disease
remission in patients with adult ALL (Acute Lymphoblas-
tic Leukemia) [25]. Jian confirmed that Antisense inhibi-
tion of ATM gene enhanced the radiosensitivity of head
and neck squamous cell carcinoma in mice. Therefore we
designed the experiment to verify the hypothesis whether
ATM AS-ODNs could inhibit the expression of ATM in
Hep-2 cells and furthermore increase the radio-induced
apoptosis in vitro and in vivo.
Here we show that transgenic expression of ATM AS-
ODNs into hep-2 cells on its own induced the inhibitory
expression of ATM at mRNA and protein level in hep-2
cells. We detected that expression of ATM was notably
Figure 5 Effect of ATM AS-ODNs on the ATM protein
expression in vivo. (A) In the group treated with ATM AS-ODNs
alone (ATM AS-ODNs treated alone) and the group irradiated in
combination with ATM AS-ODNs (ATM AS-ODNs + irradiation), the
expression of ATM protein were decreased. (B) * P < 0.05, compared
with the group irradiated in combination with ATM AS-ODNs and
the group irradiated alone.
Figure 6 Tumor growth in ATM AS-ODNs treated Hep-2 cells in
BALB/c-nu/nu mice with or without irradiation.
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lower after cell transfection with ATM AS-ODNs than
Sen-ODNs, Mis-ODNs and control ODNs, which
showed that the inhibition was specific for the ATM
antisense sequence. Then we studied whether the reduc-
tion of ATM expression resulted in radio-induced apop-
tosis enhancing in hep-2 cells. The results of clonogenic
survival assay and SF4 demonstrated that the cloning
efficiency and SF4 declined notably in cells transfected
with ATM AS-ODNs at the same dose of radiation (P <
0.05) compared with untreated cells or cells treated with
liposome, which means the increase of cell apoptosis. By
flow cytometry, we found that the apoptotic rate (Apo)
in ATM AS-ODNs treated cells was higher than that in
Sen-ODNs and Mis-ODNs treated cells after irradiation.
In the study, we also investigated the effects of ATM
AS-ODNs on the apoptotic responses to ionizing radia-
tion in vivo. It was obvious that there were a significant
difference between the tumors irradiated in combination
with the treatment of ATM AS-ODNs and controlling
tumor. The inhibition rate in the tumors injected with
ATM AS-ODNs before exposure to X-ray was 34.28 ±
2.43%, whereas it was 5.95 ± 4.52% in tumors exposed
to radiation alone (P < 0.05). The results of TUNEL
assay demonstrated that the apoptotic rate of the
tumors irradiated in combination with the treatment of
ATM AS-ODNs was notably higher than that of control
groups. The findings in vivo experiments manifested
that the radio-induced apoptosis of hep-2 cells in solid
tumors were enhanced by the treatment of ATM AS-
ODNs, which may be related with the increased radio-
sensitivity and radiation-induced apoptosis. Jian and col-
leagues have shown that antisense oligodeoxynucleotides
of ATM enhances the radiosensitivity of head and neck
squamous cell carcinoma in mice [16,17]. We had
demonstrated that the ATM AS-ODNs could specifically
reduce the ATM expression and increase radio-induced
Figure 7 The apoptosis of Hep-2 cells in vivo after irradiation. (A) The detection of apoptotic cells are by TUNEL. The nuclei of apoptotic
cells were stained brown as observed under light microscopy (magnification, × 400). (B) The apoptotic rate of tumor cells treated by irradiation
in combination with ATM AS-ODNs was raised. * P < 0.05, the AI of tumors treated with irradiation in combination with ATM AS-ODNs
compared with the untreated group and the group treated with ATM AS-ODNs alone. ** P < 0.05, compared with the other groups.
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apoptosis in hep-2 cell line. It is first reported with AS-
ODNs of ATM strengthening radio-induced apoptosis
of hep-2 cell line grown in nude mice.
In conclusion, radiotherapy combined with AS-ODNs
could specifically reduce the ATM expression and
increase radio-induced apoptosis in hep-2 cell line. This
approach might have great potential for the clinical
treatment of many tumors.
Conclusion
We had demonstrated that the ATM AS-ODNs could
specifically reduce the ATM expression and increase
radio-induced apoptosis in hep-2 cells in vitro and in
vivo in our study.
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